Saint-Gilles Pharma
ActiveSummary
Saint-Gilles Pharma has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €252,269 and a net result of €10,615. Equity has been growing by about 9.4% per year since 2019. Its solvency ranks better than 61% of 22,773 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 07-11-2018 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Establishment unit
- 2.281.771.184 4000 Liège, since 07-11-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 28-06-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €77,032
- ▼ 10.2%
- Turnover
- ≈ €370,000
- estimated
- Profit
- €10,615
- ▼ 42.0%
- Equity
- €252,269
- ▲ 4.4%
- Total assets
- €556,225
- ▼ 12.8%
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.74, cash €273,760Size: total assets €556,225Figures for financial year 2025 (filed on 09-07-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 60% of them on solvency, 92% on liquidity, 53% on profitability and 51% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 15 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Change of role: Stéphanie IOVINE, from manager to director
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Saint-Gilles Pharma: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €550,000 and €660,000, founded between 2016 and 2019.
| Company | Total assets | Gross margin |
|---|---|---|
| Saint-Gilles Pharma Liège | €556,225 | €77,032 |
| FARMINCO Andenne | €589,804 | €69,828 |
| VdC Invest Lierde | €660,114 | €72,241 |
| APOTHEEK RYCKAERT-VERBEECK Lievegem | €550,346 | €71,757 |
| JANOS RABBIT ADVISORY Genk | €554,645 | €82,978 |
| IGS PHARMA Sint-Gillis (bij-Brussel) | €656,335 | €86,248 |
| Apotheek Berckenbosch Leuven | €652,803 | €64,957 |
Key facts about Saint-Gilles Pharma
- What is the company number of Saint-Gilles Pharma?
- The company number of Saint-Gilles Pharma is 0712.909.319. The VAT number is the same number with BE in front: BE 0712.909.319.
- Where is Saint-Gilles Pharma based?
- The registered office is at Rue Saint-Gilles 278, 4000 Liège.Company details
- What does Saint-Gilles Pharma do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Saint-Gilles Pharma?
- The legal form of Saint-Gilles Pharma is Private limited company (BV).
- When was Saint-Gilles Pharma founded?
- Saint-Gilles Pharma was founded on 07-11-2018.
- Is Saint-Gilles Pharma still active?
- Yes, Saint-Gilles Pharma is an active enterprise in the KBO register.
- How many employees does Saint-Gilles Pharma have?
- Saint-Gilles Pharma had an average of 0.9 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
- What is the turnover of Saint-Gilles Pharma?
- The turnover in financial year 2025 is ≈ €370,000. This figure is estimated from the gross margin of €77,032 and 44 comparable companies (NACE 477). It probably lies between €190,000 and €510,000.
- Is Saint-Gilles Pharma profitable?
- In financial year 2025, Saint-Gilles Pharma made a profit of €10,615.
- Where can I find the annual accounts of Saint-Gilles Pharma?
- Saint-Gilles Pharma filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Saint-Gilles Pharma due?
- Saint-Gilles Pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.